Abstract
Primary CNS lymphoma is a rare and aggressive form of extranodal non-Hodgkin lymphoma. It is classically confined to the brain, eyes, and cerebrospinal fluid. Through this chapter, we aim to test the readers’ knowledge on the subtypes, molecular genetics, and the latest treatment modalities of primary CNS lymphoma with the aid of seventeen questions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol. 2017;35(21):2410–8. https://doi.org/10.1200/JCO.2017.72.7602. Epub 2017 Jun 22
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncology. 2019;21(Suppl 5):v1–v100. https://doi.org/10.1093/neuonc/noz150.
Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol. 2010;67(3):291–7. https://doi.org/10.1001/archneurol.2010.3.
Kumar V, Shrivastava SM, TrishalaMeghal T, Chandra BA. Recent advances in diffuse large B cell lymphoma. In: Guenova M, Balatzenko G, editors. Hematology - latest research and clinical advances [Internet]. London: IntechOpen; 2018. [cited 2022 Jun 15]. https://www.intechopen.com/chapters/60573. https://doi.org/10.5772/intechopen.74263.
Chen K, Ma Y, Ding T, Zhang X, Chen B, Guan M. Effectiveness of digital PCR for MYD88L265P detection in vitreous fluid for primary central nervous system lymphoma diagnosis. Exp Ther Med. 2020;20(1):301–8. https://doi.org/10.3892/etm.2020.8695. Epub 2020 Apr 29
Lukas RV, Stupp R, Gondi V, et al. Primary central nervous system lymphoma-PART 1: Epidemiology, diagnosis, staging, and prognosis. Oncology (Williston Park). 2018;32(1):17–22.
Schaff LR, Lobbous M, Carlow D, Schofield R, Gavrilovic IT, Miller AM, Stone JB, Piotrowski AF, Sener U, Skakodub A, Acosta EP, Ryan KJ, Mellinghoff IK, DeAngelis LM, Nabors LB, Grommes C. Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study. BMC Cancer. 2022;22(1):60. https://doi.org/10.1186/s12885-021-09164-x.
Robak E, Robak T. Bruton’s kinase inhibitors for the treatment of immunological diseases: current status and perspectives. J Clin Med. 2022;11(10):2807. https://doi.org/10.3390/jcm11102807.
Gao Y, Wei L, Kim SJ, Wang L, He Y, Zheng Y, Bertero L, Pellerino A, Cassoni P, Tamagnone L, Theresa PK, Deutsch A, Zhan H, Lai J, Wang Y, You H. A novel prognostic marker for primary CNS lymphoma: lactate dehydrogenase-to-lymphocyte ratio improves stratification of patients within the low and intermediate MSKCC risk groups. Front Oncol. 2021;3(11):696147. https://doi.org/10.3389/fonc.2021.696147.
Ferreri AJM. Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents. Hematology Am Soc Hematol Educ Program. 2017;2017(1):565–77. https://doi.org/10.1182/asheducation-2017.1.565.
Fink EC, Ebert BL. The novel mechanism of lenalidomide activity. Blood. 2015;126(21):2366–9. https://doi.org/10.1182/blood-2015-07-567958. Epub 2015 Oct 5
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Das, J.M. (2023). Primary CNS Lymphoma. In: Neuro-Oncology Explained Through Multiple Choice Questions. Springer, Cham. https://doi.org/10.1007/978-3-031-13253-7_23
Download citation
DOI: https://doi.org/10.1007/978-3-031-13253-7_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13252-0
Online ISBN: 978-3-031-13253-7
eBook Packages: MedicineMedicine (R0)